Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1991 Jan;37:185–187.

Antidiarrheal Agents: More to the Apple Sauce Than You Might Think

Treating infectious diarrheas

Nevio Cimolai, James E Carter
PMCID: PMC2145155  PMID: 21234091

Abstract

Recent advances have now made it possible to target specific therapy for infectious diarrheas for individual microbes that are well established as diarrheal pathogens. Improvements in non-specific therapy have particularly addressed hydration, electrolyte balance, and nutritional intake. As our understanding of the infectious diarrheas continues to progress, we can anticipate further improvement.

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cimolai N., Carter J. E., Morrison B. J., Anderson J. D. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome. J Pediatr. 1990 Apr;116(4):589–592. doi: 10.1016/s0022-3476(05)81609-9. [DOI] [PubMed] [Google Scholar]
  2. DuPont H. L., Hornick R. B. Adverse effect of lomotil therapy in shigellosis. JAMA. 1973 Dec 24;226(13):1525–1528. [PubMed] [Google Scholar]
  3. FORMAL S. B., ABRAMS G. D., SCHNEIDER H., SPRINZ H. Experimental Shigella infections. VI. Role of the small intestine in an experimental infection in guinea pigs. J Bacteriol. 1963 Jan;85:119–125. doi: 10.1128/jb.85.1.119-125.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gransden W. R., Damm M. A., Anderson J. D., Carter J. E., Lior H. Further evidence associating hemolytic uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7. J Infect Dis. 1986 Sep;154(3):522–524. doi: 10.1093/infdis/154.3.522. [DOI] [PubMed] [Google Scholar]
  5. Johnson P. C., Ericsson C. D., DuPont H. L., Morgan D. R., Bitsura J. A., Wood L. V. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea. JAMA. 1986 Feb 14;255(6):757–760. [PubMed] [Google Scholar]
  6. Karmali M. A., Petric M., Lim C., Fleming P. C., Arbus G. S., Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985 May;151(5):775–782. doi: 10.1093/infdis/151.5.775. [DOI] [PubMed] [Google Scholar]
  7. Kent T. H., Formal S. B., Labrec E. H. Acute enteritis due to Salmonella typhimurium in opium-treated guinea pigs. Arch Pathol. 1966 Jun;81(6):501–508. [PubMed] [Google Scholar]
  8. Manville I. A., Bradway E. M., McMinis A. S. The Use of Apple Powder in the Treatment of Diarrhoeal Conditions and its Rationale. Can Med Assoc J. 1937 Mar;36(3):252–257. [PMC free article] [PubMed] [Google Scholar]
  9. Novak E., Lee J. G., Seckman C. E., Phillips J. P., DiSanto A. R. Unfavorable effect of atropine-diphenoxylate (Lomotil) therapy in lincomycin-caused diarrhea. JAMA. 1976 Apr 5;235(14):1451–1454. [PubMed] [Google Scholar]
  10. Pittman F. E. Letter: Adverse effects of Lomotil. Gastroenterology. 1974 Aug;67(2):408–410. [PubMed] [Google Scholar]
  11. Portnoy B. L., DuPont H. L., Pruitt D., Abdo J. A., Rodriguez J. T. Antidiarrheal agents in the treatment of acute diarrhea in children. JAMA. 1976 Aug 16;236(7):844–846. [PubMed] [Google Scholar]
  12. Sprinz H. Pathogenesis of intestinal infections. Arch Pathol. 1969 Jun;87(6):556–562. [PubMed] [Google Scholar]
  13. Wagner B. M. Active coronaries, large and small. Hum Pathol. 1988 Jan;19(1):1–2. doi: 10.1016/s0046-8177(88)80305-8. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES